{
    "id": 25432,
    "fullName": "EGFR - SEPTIN14",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "EGFR-SEPTIN14 results from the fusion of EGFR and SEPTIN14, demonstrating increased cell proliferation, self-renewal, migration, and activated STAT3 signaling in cell culture (PMID: 23917401). EGFR-SEPTIN14 has been identified in glioblastoma (PMID: 26762204, PMID: 23917401).",
            "references": [
                {
                    "id": 4498,
                    "pubMedId": 26762204,
                    "title": "Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26762204"
                },
                {
                    "id": 3963,
                    "pubMedId": 23917401,
                    "title": "The integrated landscape of driver genomic alterations in glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23917401"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "EGFR - SEPTIN14",
    "createDate": "09/27/2016",
    "updateDate": "05/17/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 346288,
                "geneSymbol": "SEPTIN14",
                "terms": [
                    "SEPTIN14",
                    "SEPT14"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 8573,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Tarceva (erlotinib) inhibited cell survival of a human glioblastoma multiforme cell line harboring an EGFR-SEPT14 fusion, and inhibited tumor growth in xenograft models (PMID: 23917401).",
            "molecularProfile": {
                "id": 26359,
                "profileName": "EGFR - SEPTIN14"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3963,
                    "pubMedId": 23917401,
                    "title": "The integrated landscape of driver genomic alterations in glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23917401"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8572,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Tykerb (lapatinib) inhibited cell survival of a human glioblastoma multiforme cell line harboring an EGFR-SEPT14 fusion, and inhibited tumor growth in xenograft models (PMID: 23917401).",
            "molecularProfile": {
                "id": 26359,
                "profileName": "EGFR - SEPTIN14"
            },
            "therapy": {
                "id": 787,
                "therapyName": "Lapatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3963,
                    "pubMedId": 23917401,
                    "title": "The integrated landscape of driver genomic alterations in glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23917401"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26359,
            "profileName": "EGFR - SEPTIN14",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}